To delineate immunomodulatory role of histamine on antibody generation profile in rabbit in the present dose-dependent histamine study. The cohort comprised of three groups (III, IV and V), containing six rabbits each, and received subcutaneous histamine 50 μ g/kg × bis in die (b.i.d.), 100 μg/kg × b.i.d. and 200 μg/kg × b.i.d., respectively for 10 days (starting from the 1st day). They were subsequently immunized on the 3rd day with intravenous injection of sheep blood cell (SRBC) (1×109 cells/mL). Group II (positive control) (n=6) received vehicle (sterile distilled water) and immunized at day 3 similarly while group I (negative control) (n=6) remained non-immunized and received only vehicle. All experimentations were performed in triplicate. Blood samples were collected on pre-immunization (pre-I) (day 0), as well as on days 7-, 14-, 21-, 28- and 58- post-immunization (post-I). Immunological parameters [total immunoglobulins (Igs), IgM and IgG] were analyzed by enzyme linked immunosorbent assay (ELISA) technique. Histamine could influence a detectable antibody response to SRBC as early as day 7-post-I, which lasted until day 58- post-I. The results were found statistically significant (P < 0.05). Our results provide evidence that histamine has a short-term effect on antibody generation (until its presence in the body), and the antibody generation titer in vivo were affected by the concentration of histamine.
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: